|Articles|October 19, 2009
Pharma's Emerging Leaders - Podcast series
Pharm Exec interviews some of this year's emerging leaders to learn their strategies for success.
Advertisement
Michelle Dipp, Vice President and Head of US Center of Excellence for External Drug Discovery, GlaxoSmithKline
Paulash Mohsen, shares with us the “hallmark of innovation” while shedding light on the therapeutic areas of today.
Jennifer Spear Smith, Executive Director, Medical Education, Wyeth
Joe Shields Product Director, Enbrel, Wyeth
Scott Cormack President and CEO OncoGenex Pharmaceuticals
Frank Karbe talks about the biopharmaceutical space and why innovation is so important when it comes to the commercialization of new ideas.
Virginia Carnahan, believes that the successful pharmaceutical CEO of the future will dedicate significant attention to three areas: the payers, the physicians, and the patients.
Luca Santarelli, believes that innovation happens at the boundaries between different disciplines
Newsletter
Lead with insight with the Pharmaceutical Executive newsletter, featuring strategic analysis, leadership trends, and market intelligence for biopharma decision-makers.
Advertisement
Advertisement
Advertisement
Trending on PharmExec
1
Johnson and Johnson Reveals Plan to Separate Orthopaedics Business
2
The Most-Favored-Nation Policy: Outlook and Implications Beyond U.S.
3
Nabla Bio Enters $1 Billion Multi-Year Research Collaboration with Takeda
4
The Evolving Landscape in Psychiatry: Challenges and Opportunities for Biopharma
5
